AbCellera Biologics Inc.
US ˙ NasdaqGS ˙ CA00288U1066

SecurityABCL / AbCellera Biologics Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership4,209,052 shares
Latest Disclosed Value $ 14,689,591
UBS Group AG ownership in ABCL / AbCellera Biologics Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 4,209,052 shares of AbCellera Biologics Inc. (US:ABCL) valued at $14,689,591 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 1,939,409 shares of AbCellera Biologics Inc.. This represents a change in shares of 117.03% during the quarter. The current value of the position is $24,075,777 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (ABCL) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ABCL / AbCellera Biologics Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 4,209,052 2,269,643 117.03 14,690 121.49 0.0022
2026-01-29 2025-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 1,939,409 -549,791 -22.09 6,633 -47.03 0.0011
2025-11-13 2025-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 2,489,200 -958,725 -27.81 12,521 5.87 0.0020
2025-08-14 2025-06-30 13F ABCELLERA BIOLOGICS COM 00288U106 3,447,925 -1,634,258 -32.16 11,826 4.35 0.0020
2025-05-13 2025-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 5,082,183 3,106,835 157.28 11,333 95.84 0.0021
2025-02-14 2024-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 1,975,348 1,953,603 8,984.15 5,788 10,233.93 0.0011
2024-11-14 2024-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 21,745 -73,246 -77.11 57 -80.07 0.0000
2024-08-14 2024-06-30 13F ABCELLERA BIOLOGICS COM 00288U106 94,991 -6,984 -6.85 281 -39.05 0.0001
2024-05-13 2024-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 101,975 99,475 3,979.00 462 3,192.86 0.0001
2024-02-09 2023-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 2,500 2,500 14 0.0000
2023-11-09 2023-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 0 -13,366 -100.00 0 -100.00
2023-08-11 2023-06-30 13F ABCELLERA BIOLOGICS COM 00288U106 13,366 -53,532 -80.02 86 -82.94 0.0000
2023-05-12 2023-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 66,898 22,652 51.20 504 12.50 0.0002
2023-02-08 2022-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 44,246 -50,592 -53.35 448 -52.24 0.0002
2022-11-10 2022-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 94,838 53,483 129.33 938 113.18 0.0004
2022-08-10 2022-06-30 13F ABCELLERA BIOLOGICS COM 00288U106 41,355 -21,070 -33.75 440 -27.75 0.0002
2022-05-16 2022-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 62,425 -16,766 -21.17 609 -46.20 0.0002
2022-02-14 2021-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 79,191 15,784 24.89 1,132 -10.87 0.0003
2021-11-15 2021-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 63,407 22,389 54.58 1,270 40.80 0.0004
2021-08-13 2021-06-30 13F ABCELLERA BIOLOGICS COM 00288U106 41,018 37,949 1,236.53 902 767.31 0.0003
2021-05-12 2021-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 3,069 3,061 38,262.50 104 0.0000
2021-02-11 2020-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 8 8 0 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-05-12 2023-03-31 13F ABCELLERA BIOLOGICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-08 2022-12-31 13F ABCELLERA BIOLOGICS COM Call 30,000 -87.96 304 -87.70 n/a n/a n/a
2022-11-10 2022-09-30 13F ABCELLERA BIOLOGICS COM Call 249,100 2,464 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.